Wilson Therapeutics Company

Wilson Therapeutics focuses on developing novel therapies addressing unmet medical needs in rare diseases.

Last Funding Type: Venture - Series Unknown
Funding Status: M&A
Headquarters: Stockholm, Stockholms Lan, Sweden
Founded Date: 2012
Investor Type: For Profit
Total Funding: $27.2M
Technology: Cancer
Employee Number: 11-50
Estimated Revenue: $10M to $50M
Investors Number: 2
Industry: PharmTech